Evolution of ideas about the risk of tyramine syndrome developing during therapy with irreversible non-selective monoamine oxidase inhibitors (to the 70th anniversary of the first use of this group of antidepressants)
We describe the history of studying of the problem of tyramine syndrome during the treatment with antidepressants, irreversible non-selective monoamine oxidase inhibitors. Data on clinical observations are presented. Early hypotheses of pathogenesis are considered. The period of discovery of the rel...
Main Authors: | D. S. Danilov, M. Yu. Brovko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2022-10-01
|
Series: | Неврология, нейропсихиатрия, психосоматика |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/1884 |
Similar Items
-
Detection of Histamine and Tyramine in some Cheese
by: Thannae M. Amine, et al.
Published: (2007-12-01) -
Administration of Supplemental L-Tyrosine with Phenelzine: A Clinical Literature Review [Expression of Concern]
by: Hinz M, et al.
Published: (2020-04-01) -
Administration of Supplemental L-Tyrosine with Phenelzine: a Clinical Literature Review [Retraction]
by: Hinz M, et al.
Published: (2021-03-01) -
The History of Irreversible Non-Selective MAOI Antidepressants in Russia (for their 70th Anniversary)
by: D. S. Danilov
Published: (2023-06-01) -
Monoamine Oxidases (MAOs) as Privileged Molecular Targets in Neuroscience: Research Literature Analysis
by: Andy Wai Kan Yeung, et al.
Published: (2019-05-01)